| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C22H24N2O8
|
|---|
| Exact mass |
444.1533
|
|---|
| Mol weight |
444.4346
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map01057 | Biosynthesis of type II polyketide products |
| map01110 | Biosynthesis of secondary metabolites |
|
|---|
| Module |
| M00780 | Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline |
| M00823 | Chlortetracycline biosynthesis, pretetramide => chlortetracycline |
|
|---|
| Enzyme |
|
|---|
| Brite |
Compounds with biological roles [BR:br08001]
Antibiotics
Polyketides and nonribosomal peptides
Tetracyclines
C06570 Tetracycline
Lipids [BR:br08002]
PK Polyketides
PK07 Linear tetracyclines
C06570 Tetracycline
Secondary metabolites in pathway maps [br08011.html]
Biosynthetic pathways and modules of secondary metabolites
C06570
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A01 STOMATOLOGICAL PREPARATIONS
A01A STOMATOLOGICAL PREPARATIONS
A01AB Antiinfectives and antiseptics for local oral treatment
A01AB13 Tetracycline
D00201 Tetracycline (JAN/USP/INN)
D DERMATOLOGICALS
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D06A ANTIBIOTICS FOR TOPICAL USE
D06AA Tetracycline and derivatives
D06AA04 Tetracycline
D00201 Tetracycline (JAN/USP/INN)
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01A TETRACYCLINES
J01AA Tetracyclines
J01AA07 Tetracycline
D00201 Tetracycline (JAN/USP/INN)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AA Antibiotics
S01AA09 Tetracycline
D00201 Tetracycline (JAN/USP/INN)
S02 OTOLOGICALS
S02A ANTIINFECTIVES
S02AA Antiinfectives
S02AA08 Tetracycline
D00201 Tetracycline (JAN/USP/INN)
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S03A ANTIINFECTIVES
S03AA Antiinfectives
S03AA02 Tetracycline
D00201 Tetracycline (JAN/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Tetracycline
D00201 Tetracycline (JAN/USP/INN)
Drug groups [BR:br08330]
Antibacterial
DG01197 Tetracycline antibiotic
DG00005 Tetracycline
D00201 Tetracycline
Antimicrobials [BR:br08307]
Antibacterials
Protein biosynthesis inhibitor
Tetracycline
D00201 Tetracycline (JAN/USP/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 32
1 C1y C 26.1816 -17.5899
2 C1z C 26.1641 -18.9900
3 C1x C 24.9807 -16.8809
4 C1y C 27.4061 -16.9103
5 C2y C 24.9515 -19.6756
6 C5x C 27.3652 -19.7048
7 O1a O 26.1465 -20.3845
8 C1y C 23.7621 -17.5665
9 C2y C 28.6013 -17.6251
10 N1c N 27.4236 -15.5100
11 C2y C 23.7504 -18.9666
12 O1a O 24.9455 -21.0816
13 C2y C 28.6538 -19.0252
14 O5x O 27.3418 -21.1050
15 C1z C 22.5493 -16.8634
16 O1a O 29.8258 -16.9455
17 C1a C 28.6481 -14.8247
18 C1a C 26.2226 -14.7894
19 C5x C 22.5376 -19.6639
20 C5a C 29.7847 -19.7401
21 C8y C 21.3366 -17.5605
22 C1a C 22.5551 -15.4632
23 C8y C 21.3306 -18.9608
24 O5x O 22.5376 -21.0700
25 N1a N 31.0092 -19.0605
26 O5a O 29.7672 -21.1461
27 C8x C 20.1239 -16.8575
28 C8y C 20.1239 -19.6639
29 C8x C 18.9053 -17.5605
30 C8x C 18.9053 -18.9608
31 O1a O 20.1296 -21.0641
32 O1a O 21.3365 -16.1632
BOND 35
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 2 7 1 #Down
7 3 8 1
8 4 9 1
9 4 10 1 #Down
10 5 11 2
11 5 12 1
12 6 13 1
13 6 14 2
14 8 15 1
15 9 16 1
16 10 17 1
17 10 18 1
18 11 19 1
19 13 20 1
20 15 21 1
21 15 22 1 #Down
22 19 23 1
23 19 24 2
24 20 25 1
25 20 26 2
26 21 27 2
27 23 28 2
28 27 29 1
29 28 30 1
30 28 31 1
31 8 11 1
32 9 13 2
33 21 23 1
34 29 30 2
35 15 32 1 #Up
|
|---|
